Jilin Jian Yisheng Pharmaceutical Co., Ltd.

SZSE:002566.SZ

8.52 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 836.206830.041877.93842.591,012.748975.0881,034.442939.013819.598787.894643.897600.503528.925516.224414.884311.753267.837226.374
Cost of Revenue 246.343216.526220.536214.703249.51222.836268.651249.1217.397252.654169.276183.903134.403124.956104.50673.85969.73264.874
Gross Profit 589.863613.515657.393627.887763.238752.252765.791689.913602.202535.24474.621416.6394.522391.268310.378237.895198.106161.5
Gross Profit Ratio 0.7050.7390.7490.7450.7540.7710.740.7350.7350.6790.7370.6940.7460.7580.7480.7630.740.713
Reseach & Development Expenses 16.51618.77920.89315.71119.47219.52619.65617.52815.18727.79528.64511.0530007.5676.3825.945
General & Administrative Expenses 30.7233.86532.37636.31930.7330.28423.9226.47631.17967.45762.21922.44969.67549.43443.04215.58914.26312.783
Selling & Marketing Expenses 411.397388.921414.709402.567512.494520.62532.116517.81452.828363.287338.612277.564224.612235.445191.816142.438114.86195.674
SG&A 489.137422.785447.085438.886543.225550.904556.036544.287484.007430.743400.831300.013294.287284.88234.858158.028129.124108.457
Other Expenses 2.60963.98556.75844.56452.323-6.568-3.32422.74511.69313.59720.913-5.316-15.2954.5951.417-0.2620.131-0.042
Operating Expenses 503.045505.55524.736499.161615.019605.413619.216614.863549.049441.453411.957345.182302.032291.153240.387182.198150.519125.58
Operating Income 86.818102.665128.633109.742110.999106.696101.0258.0433.69598.40781.67895.459107.28998.21267.07350.20246.44433.916
Operating Income Ratio 0.1040.1240.1470.130.110.1090.0980.0090.0050.1250.1270.1590.2030.190.1620.1610.1730.15
Total Other Income Expenses Net 24.943-1.439-5.265-4.703-2.884-46.711-48.874-44.593-37.80516.539.77743.16720.4712.692-1.502-5.756-1.731-2.362
Income Before Tax 111.762101.226123.368105.038108.114100.12997.70130.45615.348110.288102.441114.585112.96102.80768.48949.9445.85633.558
Income Before Tax Ratio 0.1340.1220.1410.1250.1070.1030.0940.0320.0190.140.1590.1910.2140.1990.1650.160.1710.148
Income Tax Expense 15.65212.90718.67215.42315.78315.2214.90113.7054.83413.97514.93917.27516.17115.2087.3868.5789.74610.086
Net Income 94.73383.09796.0280.0676.59969.07960.0713.19410.91196.40987.31996.62796.48487.63861.12941.36736.1123.472
Net Income Ratio 0.1130.10.1090.0950.0760.0710.0580.0140.0130.1220.1360.1610.1820.170.1470.1330.1350.104
EPS 0.290.250.290.240.230.210.180.040.0330.290.260.290.310.350.250.170.150.095
EPS Diluted 0.290.250.290.240.230.210.180.040.0330.290.260.290.310.350.250.170.150.095
EBITDA 137.275161.85179.569167.688187.966180.898184.381130.18191.729146.499122.009138.775138.02119.73383.28866.30852.11340.834
EBITDA Ratio 0.1640.1950.2050.1990.1860.1860.1780.1390.1120.1860.1890.2310.2610.2320.2010.2130.1950.18